2 years ago

Envoke Secures £1 Million for Virtual Demo Platform Expansion

  • Envoke, a Leeds-based provider of a virtual demo platform, has secured £1 million in funding from NPIF - Mercia Equity Finance, a fund managed by Mercia Asset Management

  • The funding will be used to further develop the platform and expand its global reach through participation in international trade exhibitions

  • Envoke's virtual demo platform, initially developed for Thermo Fisher Scientific, allows manufacturers to showcase their equipment to remote customers without physical demonstrations

  • The platform is currently used by leading biotech equipment companies, including Bio-Rad, 10X Genomics, Roche, and Illumina

  • Envoke, which currently employs 16 people, plans to create ten additional jobs in the coming year.

      • ProblemTechnology

      "Envoke is addressing the challenge of showcasing biotech equipment to distant customers without the need to physically ship equipment or send sales staff to distant locations."

      Solution

      "Envoke provides a virtual demo platform that allows biotech equipment manufacturers to demonstrate their products remotely, thus enhancing accessibility and reducing logistical challenges."

      Covered on